Contact

All Stories

  1. Uncovering potential targets for MRSA infection treatment: a nanomedicine perspective

    Article • Expert Opinion on Therapeutic Targets, February 2026, Taylor & Francis

    Dr Calvin A Omolo

  2. A novel biomimetic and redox-responsive hybrid lipid polymer nanoparticle for targeting sepsis microenvironment and modulating inflammation

    Article • International Journal of Pharmaceutics, February 2026, Elsevier

    Dr Calvin A Omolo

  3. Formulation of pH-responsive nanoplexes based on an antimicrobial peptide and sodium alginate for targeted delivery of vancomycin against resistant bacteria

    Article • Biological Chemistry, November 2025, De Gruyter

    Dr Calvin A Omolo

  4. Enhancing activity and overcoming ciprofloxacin resistance via multifunctional nanostructured lipid carriers

    Article • Journal of Drug Delivery Science and Technology, June 2025, Elsevier

    Dr Calvin A Omolo

  5. Retrospective antimicrobial consumption surveillance at health facility level in Dodoma Region, Tanzania

    Article • BMJ Open, May 2025, BMJ

    Dr Calvin A Omolo

  6. Antimicrobial peptide-fucoidan nanoplexes: A novel multifunctional biomimetic nanocarrier for enhanced vancomycin delivery against bacterial infections and sepsis

    Article • International Journal of Pharmaceutics, March 2025, Elsevier

    Dr Calvin A Omolo

  7. Paving the Way for NLRP3 Inflammasome Inactivation Using ADAM10 and Alpha-Hemolysin: An In Silico Investigation

    Article • ACS Omega, February 2025, American Chemical Society (ACS)

    Dr Calvin A Omolo

  8. Multifunctional hyaluronic acid-based biomimetic/pH-responsive hybrid nanostructured lipid carriers for treating bacterial sepsis

    Article • Journal of Biomedical Science, February 2025, Springer Science + Business Media

    Dr Calvin A Omolo

  9. Multifunctional Dual Enzyme-Responsive Nanostructured Lipid Carriers for Targeting and Enhancing the Treatment of Bacterial Infections

    Article • ACS Applied Bio Materials, December 2024, American Chemical Society (ACS)

    Dr Calvin A Omolo

  10. Disease-Inspired Design of Biomimetic Tannic Acid–Based Hybrid Nanocarriers for Enhancing the Treatment of Bacterial-Induced Sepsis

    Article • Molecular Pharmaceutics, August 2024, American Chemical Society (ACS)

    Dr Calvin A Omolo

  11. Applications of peptides in nanosystems for diagnosing and managing bacterial sepsis

    Article • Journal of Biomedical Science, April 2024, Springer Science + Business Media

    Dr Calvin A Omolo

  12. Multi-functional pH-responsive and biomimetic chitosan-based nanoplexes for targeted delivery of ciprofloxacin against bacterial sepsis

    Article • International Journal of Biological Macromolecules, March 2024, Elsevier

    Dr Calvin A Omolo

  13. One-component lipidic bicontinuous nanospheres as a smart drug loading platform to eradicate candida biofilms in oral and vaginal infection

    Article • Nano Today, February 2024, Elsevier

    Dr Calvin A Omolo

  14. Niosomes modified with a novel pH-responsive coating (mPEG-OA) enhance the antibacterial and anti-biofilm activity of vancomycin against methicillin-resistant Staphylococcus aureus

    Article • Nano Express, January 2024, Institute of Physics Publishing

    Dr Calvin A Omolo

  15. Inflammation-responsive drug delivery nanosystems for treatment of bacterial-induced sepsis

    Article • International Journal of Pharmaceutics, September 2023, Elsevier

    Dr Calvin A Omolo

  16. Halting aberrant DNA methylation via in silico Identification of potent inhibitors of DNMT3B enzyme: Atomistic insights

    Article • Computational Biology and Chemistry, August 2023, Elsevier

    Dr Calvin A Omolo

  17. Hyaluronidase inhibitor surface-modified niosomes: An efficient strategy for antibacterial and anti-biofilm drug delivery

    Article • Materialia, August 2023, Elsevier

    Dr Calvin A Omolo

  18. Enzyme-responsive biomimetic solid lipid nanoparticles for antibiotic delivery against hyaluronidase-secreting bacteria

    Article • International Journal of Pharmaceutics, June 2023, Elsevier

    Dr Calvin A Omolo

  19. INFLUENCE OF AVAILABILITY, BARRIERS TO ACCESSIBILITY, AND UTILIZATION OF MENTAL HEALTH SERVICES ON PSYCHOLOGICAL DISTRESS STATUS OF UNDERGRADUATE STUDENTS AT UNITED STATES INTERNATIONAL UNIVERSITY-AFRICA, KENYA

    Article • May 2023, Cold Spring Harbor Laboratory Press

    Dr Calvin A Omolo

  20. Antimicrobial Hybrid Amphiphile via Dynamic Covalent Bonds Enables Bacterial Biofilm Dispersal and Bacteria Eradication

    Article • Advanced Functional Materials, February 2023, Wiley

    Dr Calvin A Omolo

  21. Dual acting acid-cleavable self-assembling prodrug from hyaluronic acid and ciprofloxacin: A potential system for simultaneously targeting bacterial infections and cancer

    Article • International Journal of Biological Macromolecules, December 2022, Elsevier

    Dr Calvin A Omolo

  22. Stimuli-responsive and biomimetic delivery systems for sepsis and related complications

    Article • Journal of Controlled Release, December 2022, Elsevier

    Dr Calvin A Omolo

  23. Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections

    Article • Journal of Controlled Release, November 2022, Elsevier

    Dr Calvin A Omolo

  24. Synthesis of pH-responsive dimethylglycine surface-modified branched lipids for targeted delivery of antibiotics

    Article • Chemistry and Physics of Lipids, November 2022, Elsevier

    Dr Calvin A Omolo

  25. Nano delivery systems to the rescue of ciprofloxacin against resistant bacteria “E. coli; P. aeruginosa; Saureus; and MRSA” and their infections

    Article • Journal of Controlled Release, September 2022, Elsevier

    Dr Calvin A Omolo

  26. A hyaluronic acid-based nanogel for the co-delivery of nitric oxide (NO) and a novel antimicrobial peptide (AMP) against bacterial biofilms

    Article • International Journal of Biological Macromolecules, May 2022, Elsevier

    Dr Calvin A Omolo

  27. Formulation of pH responsive multilamellar vesicles for targeted delivery of hydrophilic antibiotics

    Article • Colloids and Surfaces B Biointerfaces, November 2021, Elsevier

    Dr Calvin A Omolo

  28. Development of niosomes for encapsulating captopril-quercetin prodrug to combat hypertension

    Article • International Journal of Pharmaceutics, November 2021, Elsevier

    Dr Calvin A Omolo

  29. Surface modification of nano‐drug delivery systems for enhancing antibiotic delivery and activity

    Article • Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, October 2021, Wiley

    Dr Calvin A Omolo

  30. A transferosome-loaded bigel for enhanced transdermal delivery and antibacterial activity of vancomycin hydrochloride

    Article • International Journal of Pharmaceutics, September 2021, Elsevier

    Dr Calvin A Omolo

  31. Biomimetic pH/lipase dual responsive vitamin-based solid lipid nanoparticles for on-demand delivery of vancomycin

    Article • International Journal of Pharmaceutics, September 2021, Elsevier

    Dr Calvin A Omolo

  32. Chitosan-Based Hydrogel for the Dual Delivery of Antimicrobial Agents Against Bacterial Methicillin-Resistant Staphylococcus aureus Biofilm-Infected Wounds

    Article • ACS Omega, August 2021, American Chemical Society (ACS)

    Dr Calvin A Omolo

  33. Formulation of pH-responsive lipid-polymer hybrid nanoparticles for co-delivery and enhancement of the antibacterial activity of vancomycin and 18β-glycyrrhetinic acid

    Article • Journal of Drug Delivery Science and Technology, August 2021, Elsevier

    Dr Calvin A Omolo

  34. Photodynamic Antimicrobial Chemotherapy: Advancements in Porphyrin-Based Photosensitize Development

    Article • Frontiers in Chemistry, April 2021, Frontiers

    Dr Calvin A Omolo

  35. Nano/Microparticles Encapsulation Via Covalent Drug Conjugation

    Article • January 2021, IntechOpen

    Dr Calvin A Omolo

  36. Formulation of pH-Responsive Quatsomes from Quaternary Bicephalic Surfactants and Cholesterol for Enhanced Delivery of Vancomycin against Methicillin Resistant Staphylococcus aureus

    Article • Pharmaceutics, November 2020, MDPI AG

    Dr Calvin A Omolo

  37. Novel formulation of antimicrobial peptides enhances antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA)

    Article • Amino Acids, October 2020, Springer Science + Business Media

    Dr Calvin A Omolo

  38. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus

    Article • European Journal of Pharmacology, September 2020, Elsevier

    Dr Calvin A Omolo

  39. A self-assembled polymer therapeutic for simultaneously enhancing solubility and antimicrobial activity and lowering serum albumin binding of fusidic acid

    Article • Journal of Biomolecular Structure and Dynamics, August 2020, Taylor & Francis

    Dr Calvin A Omolo

  40. Supramolecular self-assembled drug delivery system (SADDs) of vancomycin and tocopherol succinate as an antibacterial agent:in vitro,in silicoandin vivoevaluations

    Article • Pharmaceutical Development and Technology, August 2020, Taylor & Francis

    Dr Calvin A Omolo

  41. pH-Responsive Micelles From an Oleic Acid Tail and Propionic Acid Heads Dendritic Amphiphile for the Delivery of Antibiotics

    Article • Journal of Pharmaceutical Sciences, August 2020, Elsevier

    Dr Calvin A Omolo

  42. Free radical-releasing systems for targeting biofilms

    Article • Journal of Controlled Release, June 2020, Elsevier

    Dr Calvin A Omolo

  43. Amphiphilic Dendrimers for Drug Delivery

    Article • March 2020, Taylor & Francis

    Dr Calvin A Omolo

  44. Novel chitosan-based pH-responsive lipid-polymer hybrid nanovesicles (OLA-LPHVs) for delivery of vancomycin against methicillin-resistant Staphylococcus aureus infections

    Article • International Journal of Biological Macromolecules, March 2020, Elsevier

    Dr Calvin A Omolo

  45. Supramolecular amphiphiles of Beta-cyclodextrin and Oleylamine for enhancement of vancomycin delivery

    Article • International Journal of Pharmaceutics, January 2020, Elsevier

    Dr Calvin A Omolo

  46. Liposomes with pH Responsive “On and Off” Switches for Targeted and Intracellular Delivery of Antibiotics

    Article • Journal of Liposome Research, October 2019, Taylor & Francis

    Dr Calvin A Omolo

  47. pH-Responsive Lipid–Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens

    Article • Molecular Pharmaceutics, October 2019, American Chemical Society (ACS)

    Dr Calvin A Omolo

  48. Novel fatty acid-based pH-responsive nanostructured lipid carriers for enhancing antibacterial delivery

    Article • Journal of Drug Delivery Science and Technology, October 2019, Elsevier

    Dr Calvin A Omolo

  49. Novel two-chain fatty acid-based lipids for development of vancomycin pH-responsive liposomes against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA)

    Article • Journal of Drug Targeting, March 2019, Taylor & Francis

    Rahul Kalhapure, Dr Ayman Yahia Waddad, Dr Calvin A Omolo

  50. Delivery of novel vancomycin nanoplexes for combating methicillin resistant Staphylococcus aureus (MRSA) infections

    Article • International Journal of Pharmaceutics, March 2019, Elsevier

    Dr Calvin A Omolo

  51. A hybrid of mPEG-b-PCL and G1-PEA dendrimer for enhancing delivery of antibiotics

    Article • Journal of Controlled Release, November 2018, Elsevier

    Dr Calvin A Omolo

  52. Synthesis of an oleic acid based pH-responsive lipid and its application in nanodelivery of vancomycin

    Article • International Journal of Pharmaceutics, October 2018, Elsevier

    Dr Calvin A Omolo

  53. Antimicrobial cell penetrating peptides with bacterial cell specificity: Pharmacophore modelling, Quantitative Structure Activity Relationship and Molecular Dynamics Simulation

    Article • Journal of Biomolecular Structure and Dynamics, July 2018, Taylor & Francis

    Dr Calvin A Omolo, Rahul Kalhapure

  54. Formulation and Molecular Dynamics Simulations of a Fusidic Acid Nanosuspension for Simultaneously Enhancing Solubility and Antibacterial Activity

    Article • Molecular Pharmaceutics, June 2018, American Chemical Society (ACS)

    Dr Calvin A Omolo

  55. Conjugates and nano-delivery of antimicrobial peptides for enhancing therapeutic activity

    Article • Journal of Drug Delivery Science and Technology, April 2018, Elsevier

    Dr Calvin A Omolo

  56. Pegylated oleic acid: A promising amphiphilic polymer for nano-antibiotic delivery

    Article • European Journal of Pharmaceutics and Biopharmaceutics, March 2017, Elsevier

    Dr Calvin A Omolo